Skip to main content
Skip to footer

Evaluating Global Regulatory Landscape for Driving Digital Innovation in Supply Management

Digitalization of clinical supply management

Dr. Paul Ingram

, Industry Leader, Supply Management TCS ADD Platforms

You have these already downloaded

We have sent you a copy of the report to your email again.

The clinical trial supply space has many examples where current practices following traditional, conservative, historically proven, and perceived “safest” approaches to delivering medication to trial participants are being favored over newer alternatives that have become available. In recent months, regulatory bodies have provided guidance and driven changes that could spur clinical trial supply-chain digitalization and innovation initiatives. This will enable life sciences industry to deliver the greatest benefits to trial participants at the receiving end and help unburden operational teams who support the process throughout. What are the digitalization avenues and how are the regulatory guidelines supporting the process?

Read More

About the author

Dr. Paul Ingram
During Dr. Ingram’s 25-year career, his work has focused on pharmaceutical research and development and medical devices. He has over 15 years of experience in clinical supplies, working in both Phase 1 unit manufacturing suites and trial supplies service companies, including Quintiles (later Aptuit), Fisher Clinical and Catalent.
Read more about authorRead more about author Read more about author

Related reading

The new age digital contract research organizations

White Paper | 22 Dec 2022

The Future of Regulatory Intelligence with Conversational AI

White Paper | 22 Dec 2022

Smart Medication Management

White Paper | 22 Dec 2022

Technology-Driven EDC Platform for Medical Device Trials

White Paper | 22 Dec 2022

Transformation starts here

Learn how we can help you bring drugs to the market faster.

Talk to our experts

Find out more